Last reviewed · How we verify
BOTOX-A
BOTOX-A is a Small molecule drug developed by Baylor College of Medicine. It is currently FDA-approved. Also known as: BTX-A, Botulinum Toxin Type A, Generic Name: Botulinum toxin type A.
At a glance
| Generic name | BOTOX-A |
|---|---|
| Also known as | BTX-A, Botulinum Toxin Type A, Generic Name: Botulinum toxin type A |
| Sponsor | Baylor College of Medicine |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (PHASE4)
- DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia (PHASE1,PHASE2)
- DaxibotulinumtoxinA for Blepharospasm (PHASE2)
- Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure
- Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy (PHASE3)
- Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PHASE3)
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BOTOX-A CI brief — competitive landscape report
- BOTOX-A updates RSS · CI watch RSS
- Baylor College of Medicine portfolio CI
Frequently asked questions about BOTOX-A
What is BOTOX-A?
BOTOX-A is a Small molecule drug developed by Baylor College of Medicine.
Who makes BOTOX-A?
BOTOX-A is developed and marketed by Baylor College of Medicine (see full Baylor College of Medicine pipeline at /company/baylor-college-of-medicine).
Is BOTOX-A also known as anything else?
BOTOX-A is also known as BTX-A, Botulinum Toxin Type A, Generic Name: Botulinum toxin type A.
What development phase is BOTOX-A in?
BOTOX-A is FDA-approved (marketed).
Related
- Manufacturer: Baylor College of Medicine — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Also known as: BTX-A, Botulinum Toxin Type A, Generic Name: Botulinum toxin type A
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing